mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein
Manuela Mancini, Valentina Corradi, Sara Petta, Giovanni Martinelli, Enza Barbieri, Maria Alessandra SantucciVolume:
34
Year:
2010
Language:
english
Pages:
8
DOI:
10.1016/j.leukres.2009.07.012
File:
PDF, 726 KB
english, 2010